Diagnostics and Treatment of Malignant Ovarian Tumors
Southeastern European Medical Journal · 2025
DOI: 10.26332/1xsrvv94 ↗Kurz gefasst
Fachartikel in der Zeitschrift Southeastern European Medical Journal, 2025. Verfasst von Ivana Maurac Pašalić und 3 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Malignant ovarian tumors represent a heterogeneous group of neoplasms and a significant clinical challenge. Due to non-specific symptoms in the early stages, they are often diagnosed late, resulting in poor prognosis. Diagnostic evaluation involves a combination of medical history, physical examination, tumor marker assessment, and imaging techniques. Transvaginal ultrasound is the first-line imaging modality, followed by CT, MRI, or PET/CT as needed. Accurate staging is essential for choosing the optimal therapeutic approach. Standard treatment consists of surgery and platinum-based chemotherapy, with PARP inhibitors and anti-angiogenic therapies used in maintenance. In selected young patients, fertility-sparing surgery may be considered. The management of recurrent disease is individualized based on patient characteristics, tumor biology and previous response to therapy.
Zitieren
APA
Pašalić, I. M., Šota, S., Šoletić, M., & Pavić, M. (2025). Diagnostics and Treatment of Malignant Ovarian Tumors. Southeastern European Medical Journal. https://doi.org/10.26332/1xsrvv94
Vancouver
Pašalić IM, Šota S, Šoletić M, Pavić M. Diagnostics and Treatment of Malignant Ovarian Tumors. Southeastern European Medical Journal. 2025. doi:10.26332/1xsrvv94
BibTeX
@article{Paali2025,
author = {Pašalić, Ivana Maurac and Šota, Sara and Šoletić, Miriam and Pavić, Mato},
title = {Diagnostics and Treatment of Malignant Ovarian Tumors},
journal = {Southeastern European Medical Journal},
year = {2025},
doi = {10.26332/1xsrvv94}
}
EUVIMED